AHR and inflammatory bowel disease: The aryl hydrocarbon receptor (AhR) is one of the potential targets of RSBDP’s treatment of IBD, exerting various regulatory effects through binding to flavonoids or natural drugs and influencing the transduction of downstream signaling pathways [27,28].